Skip to main content
. 2024 Feb 13;8(3):102105. doi: 10.1016/j.cdnut.2024.102105

TABLE 2.

Overview of recommendations by a selection of scholarly institutions

Institution Type and year of publication Target population(s) Summary of recommendations regarding LCSs
WHO Guideline, 2023 [9] General population
  • LCSs should not be used as a means of achieving weight control or reducing the risk of cardiometabolic diseases.

American Heart Association Advisory paper, 2018 [47] General population and patients with diabetes
  • LCS-containing beverages can be a useful replacement strategy to reduce sugar for adults who are habitually high consumers of sugars.

  • LCS-containing beverages can help people with diabetes manage blood glucose levels.

  • Prolonged consumption of LCS-containing beverages is not advised for children.

Diabetes UK Position statement, 2018 [45] Patients with diabetes
  • Substituting LCSs for sugars may be a useful, relatively simple strategy to assist with weight management, especially for people who regularly consume sweet foods and drinks and prefer sweet taste.

  • Replacing sugars with LCSs can be a helpful strategy to aid glucose management in children and adults with diabetes.

American Diabetes Association Information on website, 2024 [46] Patients with diabetes
  • LCSs may not help manage blood sugar or weight or improve cardiometabolic health in the long term.

Abbreviation: LCS, low-calorie sweetener.